Mimidis Konstantinos, Papadopoulos Vassilios, Katsinelos Panagiotis, Deftereos Savvas, Filippou Dimitrios, Kartalis Georgios
First Department of Internal Medicine, 8 Chrisostomou Smirnis Str., GR-68 100 Alexandroupolis, Greece.
Rom J Gastroenterol. 2004 Mar;13(1):39-41.
Gastrocolic fistula is rarely described in the literature. It has been associated with a variety of diseases and recently with benign gastric ulcers related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs'). The present case represents the first report of gastrocolic fistula due to NSAIDs in a cirrhotic patient. This is in keeping with the established knowledge that cirrhotic patients constitute a high-risk group of patients when treated with NSAIDs'. Review of the literature shows that this condition warrants a complete diagnostic work-up to exclude more ominous underlined diseases.
胃结肠瘘在文献中鲜有描述。它与多种疾病有关，最近还与使用非甾体抗炎药（NSAIDs）相关的良性胃溃疡有关。本病例是肝硬化患者因使用NSAIDs导致胃结肠瘘的首例报告。这与已有的认知相符，即肝硬化患者在使用NSAIDs治疗时属于高危患者群体。文献回顾表明，对于这种情况需要进行全面的诊断检查，以排除更严重的潜在疾病。
